T1	tradename 113 118	EMEND
T2	tradename 180 193	EMEND. EMEND
T3	nanoparticle 195 221	fosaprepitant dimeglumine)
T4	routeofadministration 241 252	intravenous
T5	fdaapprovaldate 280 284	2008
T6	tradename 363 368	EMEND
T7	indication 563 569	nausea
T8	indication 574 582	vomiting
T9	indication 630 673	highly emetogenic cancer chemotherapy (HEC)
T10	indication 715 748	prevention of nausea and vomiting
T11	indication 795 842	moderately emetogenic cancer chemotherapy (MEC)
T12	indication 1014 1017	HEC
T13	tradename 1041 1046	EMEND
T14	dose 1062 1069	150 mg)
T15	tradename 1208 1213	EMEND
T16	tradename 1248 1253	EMEND
T17	indication 1292 1319	prevent nausea and vomiting
T18	indication 1331 1334	HEC
T19	indication 1407 1410	HEC
T20	indication 1415 1418	MEC
T21	tradename 1443 1448	EMEND
T22	dose 1464 1471	115 mg)
T23	tradename 1586 1591	EMEND
T24	dose 1602 1608	80 mg)
T25	routeofadministration 1619 1625	orally
T26	tradename 1643 1648	EMEND
T27	tradename 1667 1672	EMEND
T28	indication 1707 1734	prevent nausea and vomiting
T29	indication 1746 1749	HEC
T30	indication 1753 1756	MEC
T31	routeofadministration 1963 1974	intravenous
T32	dose 2019 2025	150 mg
T33	dose 2030 2036	115 mg
T34	activeingredient 2282 2292	aprepitant
T35	activeingredient 2500 2513	Fosaprepitant
T36	activeingredient 2858 2871	fosaprepitant
T37	activeingredient 2875 2885	aprepitant
T38	activeingredient 3137 3150	fosaprepitant
T39	activeingredient 3154 3164	aprepitant
T40	routeofadministration 3371 3375	oral
T41	activeingredient 3376 3386	aprepitant
T42	adversereaction 3524 3636	hiccups, asthenia/fatigue, AST/ALT increased, headache, constipation, anorexia, dyspepsia, diarrhea, eructation.
T43	tradename 3685 3690	EMEND
T44	indication 3750 3753	HEC
T45	routeofadministration 3767 3771	oral
T46	activeingredient 3772 3783	aprepitant.
T47	adversereaction 3797 3820	infusion site reactions
T48	tradename 3840 3845	EMEND
T49	company 3915 3945	Merck Sharp &amp; Dohme Corp.,
T50	company 3962 3984	Merck &amp; Co., Inc.,
T51	activeingredient 4162 4175	fosaprepitant
T52	activeingredient 4179 4189	aprepitant
T53	activeingredient 4301 4312	aprepitant,
T54	tradename 4369 4374	EMEND
T55	indication 4720 4753	Prevention of Nausea and Vomiting
T56	indication 4770 4806	Highly Emetogenic Chemotherapy (HEC)
T57	indication 4813 4846	Prevention of Nausea and Vomiting
T58	indication 4863 4903	Moderately Emetogenic Chemotherapy (MEC)
T59	tradename 4925 4930	EMEND
T60	activeingredient 5405 5429	Fosaprepitant/Aprepitant
T61	activeingredient 5526 5536	Aprepitant
T62	indication 5958 5994	Highly Emetogenic Chemotherapy (HEC)
T63	indication 6001 6041	Moderately Emetogenic Chemotherapy (MEC)
T64	tradename 6457 6462	EMEND
T65	indication 6625 6676	prevention of acute and delayed nausea and vomiting
T66	indication 6723 6766	highly emetogenic cancer chemotherapy (HEC)
T67	indication 6846 6879	prevention of nausea and vomiting
T68	indication 6926 6973	moderately emetogenic cancer chemotherapy (MEC)
T69	tradename 7033 7038	EMEND
T70	indication 7256 7289	Prevention of Nausea and Vomiting
T71	indication 7306 7342	Highly Emetogenic Chemotherapy (HEC)
T72	tradename 7344 7349	EMEND
T73	dose 7364 7370	150 mg
T74	tradename 7395 7401	EMEND)
T75	tradename 7403 7408	EMEND
T76	dose 7423 7429	150 mg
T77	routeofadministration 7446 7459	intravenously
T78	tradename 7582 7587	EMEND
T79	tradename 7622 7627	EMEND
T80	co-administereddrug 7776 7789	dexamethasone
T81	tradename 7795 7800	EMEND
T82	dose 7815 7821	150 mg
T83	co-administereddrug 7861 7874	dexamethasone
T84	tradename 7880 7885	EMEND
T85	dose 7900 7906	115 mg
T86	tradename 8039 8044	EMEND
T87	tradename 8112 8118	EMEND)
T88	tradename 8241 8246	EMEND
T89	dose 8247 8253	150 mg
T90	routeofadministration 8254 8265	intravenous
T91	co-administereddrug 8283 8297	Dexamethasone*
T92	dose 8298 8303	12 mg
T93	routeofadministration 8304 8310	orally
T94	dose 8311 8315	8 mg
T95	routeofadministration 8316 8322	orally
T96	dose 8323 8327	8 mg
T97	routeofadministration 8328 8334	orally
T98	frequency 8335 8346	twice daily
T99	dose 8348 8352	8 mg
T100	routeofadministration 8353 8359	orally
T101	frequency 8360 8371	twice daily
T102	co-administereddrug 8503 8516	Dexamethasone
T103	co-administereddrug 8645 8658	dexamethasone
T104	tradename 8693 8698	EMEND
T105	dose 8713 8719	115 mg
T106	tradename 8745 8751	EMEND)
T107	tradename 8753 8758	EMEND
T108	dose 8773 8779	115 mg
T109	tradename 8898 8903	EMEND
T110	dose 8904 8909	80 mg
T111	tradename 8950 8955	EMEND
T112	dose 8970 8976	115 mg
T113	co-administereddrug 9111 9124	dexamethasone
T114	tradename 9130 9135	EMEND
T115	dose 9150 9156	115 mg
T116	co-administereddrug 9196 9209	dexamethasone
T117	tradename 9215 9220	EMEND
T118	dose 9235 9241	150 mg
T119	tradename 9375 9380	EMEND
T120	tradename 9409 9414	EMEND
T121	dose 9415 9421	125 mg
T122	tradename 9445 9450	EMEND
T123	dose 9465 9471	115 mg
T124	tradename 9709 9715	EMEND)
T125	indication 9724 9758	prevention of nausea and vomiting
T126	indication 9775 9812	highly emetogenic cancer chemotherapy
T127	tradename 9838 9843	EMEND
T128	dose 9844 9850	115 mg
T129	routeofadministration 9851 9862	intravenous
T130	dose 9864 9869	80 mg
T131	routeofadministration 9870 9876	orally
T132	dose 9877 9882	80 mg
T133	routeofadministration 9883 9889	orally
T134	co-administereddrug 9896 9910	Dexamethasone*
T135	dose 9911 9916	12 mg
T136	routeofadministration 9917 9923	orally
T137	dose 9924 9928	8 mg
T138	routeofadministration 9929 9935	orally
T139	dose 9936 9940	8 mg
T140	routeofadministration 9941 9947	orally
T141	frequency 9948 9958	once daily
T142	dose 9960 9964	8 mg
T143	routeofadministration 9965 9971	orally
T144	frequency 9972 9982	once daily
T145	co-administereddrug 10114 10127	Dexamethasone
T146	co-administereddrug 10255 10268	dexamethasone
T147	indication 10307 10340	Prevention of Nausea and Vomiting
T148	indication 10357 10397	Moderately Emetogenic Chemotherapy (MEC)
T149	tradename 10399 10404	EMEND
T150	dose 10419 10425	115 mg
T151	tradename 10451 10457	EMEND)
T152	tradename 10459 10464	EMEND
T153	dose 10479 10485	115 mg
T154	tradename 10604 10609	EMEND
T155	dose 10610 10615	80 mg
T156	tradename 10656 10661	EMEND
T157	dose 10676 10682	115 mg
T158	co-administereddrug 10817 10830	dexamethasone
T159	tradename 10836 10841	EMEND
T160	dose 10856 10862	115 mg
T161	co-administereddrug 10902 10915	dexamethasone
T162	tradename 10921 10926	EMEND
T163	dose 10941 10947	150 mg
T164	tradename 11081 11086	EMEND
T165	tradename 11115 11120	EMEND
T166	dose 11121 11127	125 mg
T167	tradename 11151 11156	EMEND
T168	dose 11171 11177	115 mg
T169	tradename 11241 11247	EMEND)
T170	indication 11256 11289	prevention of nausea and vomiting
T171	indication 11306 11347	moderately emetogenic cancer chemotherapy
T172	tradename 11369 11374	EMEND
T173	dose 11375 11381	115 mg
T174	routeofadministration 11382 11393	intravenous
T175	dose 11394 11399	80 mg
T176	routeofadministration 11401 11407	orally
T177	dose 11409 11414	80 mg
T178	routeofadministration 11416 11422	orally
T179	co-administereddrug 11423 11437	Dexamethasone*
T180	dose 11438 11443	12 mg
T181	routeofadministration 11444 11450	orally
T182	co-administereddrug 11584 11597	Dexamethasone
T183	co-administereddrug 11686 11699	dexamethasone
T184	tradename 11753 11758	EMEND
T185	tradename 12007 12012	EMEND
T186	dose 12028 12034	115 mg
T187	dose 12039 12061	150 mg) 115 mg 150 mg
T188	inactiveingredient 12100 12115	Sodium Chloride
T189	inactiveingredient 12138 12145	saline)
T190	inactiveingredient 12180 12186	saline
T191	inactiveingredient 12358 12373	Sodium Chloride
T192	inactiveingredient 12396 12403	saline)
T193	inactiveingredient 12660 12667	saline.
T194	inactiveingredient 12734 12741	saline.
T195	inactiveingredient 12870 12876	saline
T196	inactiveingredient 13071 13077	saline
T197	tradename 13586 13591	EMEND
T198	tradename 13731 13736	EMEND
T199	dose 13932 13938	150-mg
T200	routeofadministration 14033 14044	intravenous
T201	dose 14095 14101	115-mg
T202	routeofadministration 14196 14207	intravenous
T203	tradename 14296 14301	EMEND
T204	tradename 14373 14378	EMEND
T205	activeingredient 14395 14406	aprepitant,
T206	inactiveingredient 14407 14421	polysorbate 80
T207	adversereaction 14504 14532	flushing, erythema, dyspnea,
T208	adversereaction 14537 14559	anaphylactic reactions
T209	routeofadministration 14669 14676	orally,
T210	activeingredient 14803 14816	fosaprepitant
T211	activeingredient 14841 14852	aprepitant,
T212	activeingredient 14864 14877	fosaprepitant
T213	activeingredient 15152 15162	aprepitant
T214	activeingredient 15368 15381	Fosaprepitant
T215	activeingredient 15406 15417	aprepitant,
T216	activeingredient 15524 15537	Fosaprepitant
T217	activeingredient 15683 15693	aprepitant
T218	activeingredient 15697 15710	fosaprepitant
T219	activeingredient 15798 15811	fosaprepitant
T220	activeingredient 15865 15875	aprepitant
T221	activeingredient 15923 15933	aprepitant
T222	activeingredient 16002 16012	aprepitant
T223	activeingredient 16098 16108	aprepitant
T224	activeingredient 16352 16362	aprepitant
T225	activeingredient 16672 16682	aprepitant
T226	adversereaction 17052 17078	Hypersensitivity Reactions
T227	adversereaction 17146 17174	flushing, erythema, dyspnea,
T228	adversereaction 17180 17191	anaphylaxis
T229	activeingredient 17225 17239	fosaprepitant.
T230	co-administereddrug 17516 17524	Warfarin
T231	activeingredient 17566 17579	fosaprepitant
T232	activeingredient 17583 17593	aprepitant
T233	co-administereddrug 17599 17607	warfarin
T234	co-administereddrug 17741 17749	warfarin
T235	activeingredient 17871 17884	fosaprepitant
T236	co-administereddrug 17972 17995	Hormonal Contraceptives
T237	activeingredient 18023 18036	fosaprepitant
T238	activeingredient 18040 18051	aprepitant,
T239	co-administereddrug 18068 18091	hormonal contraceptives
T240	activeingredient 18165 18178	fosaprepitant
T241	activeingredient 18182 18193	aprepitant.
T242	activeingredient 18322 18335	fosaprepitant
T243	activeingredient 18339 18349	aprepitant
T244	tradename 18435 18440	EMEND
T245	tradename 19199 19204	EMEND
T246	activeingredient 19235 19246	aprepitant,
T247	activeingredient 19287 19297	aprepitant
T248	tradename 19335 19340	EMEND
T249	activeingredient 19379 19392	fosaprepitant
T250	activeingredient 19467 19477	aprepitant
T251	routeofadministration 19528 19532	Oral
T252	activeingredient 19533 19543	Aprepitant
T253	indication 19545 19581	Highly Emetogenic Chemotherapy (HEC)
T254	indication 19643 19681	highly emetogenic cancer chemotherapy,
T255	activeingredient 19713 19723	aprepitant
T256	routeofadministration 19861 19865	Oral
T257	activeingredient 19866 19876	aprepitant
T258	co-administereddrug 19907 19918	ondansetron
T259	co-administereddrug 19923 19937	dexamethasone.
T260	activeingredient 20033 20043	aprepitant
T261	activeingredient 20216 20226	aprepitant
T262	activeingredient 20370 20380	aprepitant
T263	indication 20547 20550	HEC
T264	activeingredient 20584 20594	Aprepitant
T265	activeingredient 20632 20642	Aprepitant
T266	adversereaction 20705 20712	hiccups
T267	adversereaction 20754 20770	asthenia/fatigue
T268	adversereaction 20794 20807	ALT increased
T269	adversereaction 20816 20829	AST increased
T270	adversereaction 20855 20867	constipation
T271	adversereaction 20876 20885	dyspepsia
T272	adversereaction 20894 20902	diarrhea
T273	adversereaction 20926 20934	headache
T274	adversereaction 20968 20976	anorexia
T275	activeingredient 21024 21034	aprepitant
T276	activeingredient 21268 21278	aprepitant
T277	indication 21394 21397	HEC
T278	activeingredient 21411 21422	aprepitant.
T279	indication 21424 21464	Moderately Emetogenic Chemotherapy (MEC)
T280	indication 21524 21566	moderately emetogenic cancer chemotherapy,
T281	activeingredient 21603 21613	aprepitant
T282	activeingredient 21763 21773	aprepitant
T283	co-administereddrug 21804 21815	ondansetron
T284	co-administereddrug 21820 21833	dexamethasone
T285	activeingredient 21835 21845	aprepitant
T286	activeingredient 22001 22011	aprepitant
T287	activeingredient 22184 22194	aprepitant
T288	activeingredient 22338 22348	aprepitant
T289	indication 22710 22713	MEC
T290	activeingredient 22747 22757	Aprepitant
T291	activeingredient 22795 22805	Aprepitant
T292	adversereaction 22876 22886	eructation
T293	adversereaction 22948 22955	fatigue
T294	activeingredient 23003 23013	aprepitant
T295	indication 23238 23241	HEC
T296	indication 23245 23248	MEC
T297	activeingredient 23286 23296	aprepitant
T298	indication 23464 23467	HEC
T299	indication 23471 23474	MEC
T300	activeingredient 23516 23526	Aprepitant
T301	adversereaction 23592 23629	candidiasis, staphylococcal infection
T302	adversereaction 23673 23700	anemia, febrile neutropenia
T303	adversereaction 23738 23761	weight gain, polydipsia
T304	adversereaction 23785 23818	disorientation, euphoria, anxiety
T305	adversereaction 23845 23915	dizziness, dream abnormality, cognitive disorder, lethargy, somnolence
T306	adversereaction 23931 23945	conjunctivitis
T307	adversereaction 23975 23983	tinnitus
T308	adversereaction 24003 24053	bradycardia, cardiovascular disorder, palpitations
T309	adversereaction 24073 24092	hot flush, flushing
T310	adversereaction 24142 24205	pharyngitis, sneezing, cough, postnasal drip, throat irritation
T311	adversereaction 24235 24479	nausea, acid reflux, dysgeusia, epigastric discomfort, obstipation, gastroesophageal reflux disease, perforating duodenal ulcer, vomiting, abdominal pain, dry mouth, abdominal distension, faeces hard, neutropenic colitis, flatulence, stomatitis
T312	adversereaction 24521 24598	rash, acne, photosensitivity, hyperhidrosis, oily skin, pruritus, skin lesion
T313	adversereaction 24649 24689	muscle cramp, myalgia, muscular weakness
T314	adversereaction 24720 24750	polyuria, dysuria, pollakiuria
T315	adversereaction 24805 24871	edema, chest discomfort, malaise, thirst, chills, gait disturbance
T316	adversereaction 24888 25016	alkaline phosphatase increased, hyperglycemia, microscopic hematuria, hyponatremia, weight decreased, neutrophil count decreased
T317	adversereaction 25084 25108	Stevens-Johnson syndrome
T318	activeingredient 25175 25185	aprepitant
T319	indication 25479 25482	HEC
T320	indication 25487 25490	MEC
T321	activeingredient 25577 25590	Fosaprepitant
T322	indication 25652 25683	highly emetogenic chemotherapy,
T323	tradename 25755 25760	EMEND
T324	dose 25775 25781	150 mg
T325	tradename 25839 25844	EMEND
T326	activeingredient 25846 25857	aprepitant)
T327	indication 25922 25925	HEC
T328	activeingredient 25939 25950	aprepitant.
T329	activeingredient 26034 26047	fosaprepitant
T330	activeingredient 26086 26096	aprepitant
T331	adversereaction 26157 26250	infusion-site erythema, infusion-site pruritus, infusion-site pain, infusion-site induration,
T332	adversereaction 26255 26286	infusion-site thrombophlebitis.
T333	activeingredient 26345 26358	fosaprepitant
T334	dose 26359 26365	150 mg
T335	routeofadministration 26397 26401	oral
T336	activeingredient 26402 26412	aprepitant
T337	activeingredient 26527 26540	Fosaprepitant
T338	dose 26541 26547	150 mg
T339	routeofadministration 26580 26584	Oral
T340	activeingredient 26585 26595	Aprepitant
T341	adversereaction 26658 26750	infusion site erythema, infusion site pruritus, infusion site induration, infusion site pain
T342	adversereaction 26767 26791	blood pressure increased
T343	adversereaction 26832 26840	erythema
T344	adversereaction 26861 26877	thrombophlebitis
T345	adversereaction 26894 26925	infusion-site thrombophlebitis)
T346	dose 27099 27104	40-mg
T347	activeingredient 27105 27115	aprepitant
T348	routeofadministration 27116 27122	orally
T349	dose 27158 27162	4-mg
T350	co-administereddrug 27163 27174	ondansetron
T351	routeofadministration 27175 27189	intravenously.
T352	dose 27268 27273	40-mg
T353	activeingredient 27274 27284	aprepitant
T354	dose 27341 27345	4-mg
T355	co-administereddrug 27346 27357	ondansetron
T356	routeofadministration 27358 27372	intravenously.
T357	activeingredient 27399 27410	aprepitant,
T358	adversereaction 27411 27424	increased ALT
T359	co-administereddrug 27474 27485	ondansetron
T360	activeingredient 27576 27586	aprepitant
T361	co-administereddrug 27632 27644	ondansetron.
T362	activeingredient 27713 27723	Aprepitant
T363	dose 27724 27729	40 mg
T364	activeingredient 27763 27773	Aprepitant
T365	co-administereddrug 27792 27803	ondansetron
T366	adversereaction 27826 27834	insomnia
T367	adversereaction 27860 27905	dysarthria, hypoesthesia, sensory disturbance
T368	adversereaction 27920 27949	miosis, visual acuity reduced
T369	adversereaction 27968 27979	bradycardia
T370	adversereaction 28029 28046	dyspnea, wheezing
T371	adversereaction 28075 28157	abdominal pain upper, bowel sounds abnormal, dry mouth, nausea, stomach discomfort
T372	activeingredient 28313 28324	aprepitant:
T373	adversereaction 28392 28402	Angioedema
T374	adversereaction 28407 28416	urticaria
T375	activeingredient 28484 28494	aprepitant
T376	activeingredient 28636 28649	fosaprepitant
T377	activeingredient 28655 28666	aprepitant.
T378	adversereaction 29138 29164	pruritus, rash, urticaria,
T379	adversereaction 29172 29224	Stevens-Johnson syndrome/toxic epidermal necrolysis.
T380	adversereaction 29251 29277	hypersensitivity reactions
T381	adversereaction 29288 29311	anaphylactic reactions.
T382	adversereaction 29348 29380	ifosfamide-induced neurotoxicity
T383	activeingredient 29407 29417	aprepitant
T384	co-administereddrug 29422 29432	ifosfamide
T385	activeingredient 29519 29532	fosaprepitant
T386	routeofadministration 29583 29587	oral
T387	activeingredient 29588 29611	aprepitant. Aprepitant
T388	activeingredient 29740 29750	Aprepitant
T389	activeingredient 29782 29795	Fosaprepitant
T390	dose 29796 29803	150 mg,
T391	activeingredient 29887 29900	Fosaprepitant
T392	activeingredient 29904 29914	aprepitant
T393	routeofadministration 30059 30063	oral
T394	activeingredient 30064 30075	aprepitant,
T395	activeingredient 30103 30116	fosaprepitant
T396	routeofadministration 30121 30125	oral
T397	activeingredient 30166 30179	fosaprepitant
T398	activeingredient 30214 30238	Fosaprepitant/Aprepitant
T399	activeingredient 30299 30310	Aprepitant,
T400	activeingredient 30350 30363	fosaprepitant
T401	dose 30364 30371	150 mg,
T402	routeofadministration 30470 30474	oral
T403	activeingredient 30610 30620	aprepitant
T404	co-administereddrug 30691 30716	ondansetron, granisetron,
T405	co-administereddrug 30720 30735	hydrodolasetron
T406	co-administereddrug 30793 30807	Dexamethasone:
T407	activeingredient 30808 30821	Fosaprepitant
T408	dose 30822 30828	150 mg
T409	routeofadministration 30854 30865	intravenous
T410	co-administereddrug 30908 30922	dexamethasone,
T411	dose 30948 30952	8-mg
T412	routeofadministration 30953 30957	oral
T413	routeofadministration 31029 31033	oral
T414	co-administereddrug 31034 31047	dexamethasone
T415	activeingredient 31133 31146	fosaprepitant
T416	dose 31147 31153	150-mg
T417	routeofadministration 31154 31165	intravenous
T418	routeofadministration 31180 31184	oral
T419	activeingredient 31185 31195	aprepitant
T420	dose 31207 31213	125 mg
T421	dose 31228 31233	80 mg
T422	frequency 31233 31237	/day
T423	dose 31279 31284	20-mg
T424	routeofadministration 31285 31289	oral
T425	co-administereddrug 31290 31303	dexamethasone
T426	routeofadministration 31322 31326	oral
T427	co-administereddrug 31327 31340	dexamethasone
T428	co-administereddrug 31383 31396	dexamethasone
T429	routeofadministration 31430 31434	oral
T430	co-administereddrug 31435 31448	dexamethasone
T431	activeingredient 31532 31545	fosaprepitant
T432	dose 31546 31552	115 mg
T433	activeingredient 31565 31576	aprepitant.
T434	co-administereddrug 31578 31597	Methylprednisolone:
T435	routeofadministration 31601 31605	oral
T436	activeingredient 31606 31616	aprepitant
T437	dose 31628 31634	125 mg
T438	dose 31648 31653	80 mg
T439	frequency 31653 31657	/day
T440	co-administereddrug 31695 31713	methylprednisolone
T441	co-administereddrug 31767 31785	methylprednisolone
T442	routeofadministration 31805 31818	intravenously
T443	dose 31822 31828	125 mg
T444	routeofadministration 31842 31848	orally
T445	dose 31852 31857	40 mg
T446	routeofadministration 31879 31890	intravenous
T447	co-administereddrug 31891 31909	methylprednisolone
T448	routeofadministration 31963 31967	oral
T449	co-administereddrug 31968 31986	methylprednisolone
T450	activeingredient 32082 32082	
T451	dose 32083 32089	115 mg
T452	activeingredient 32102 32113	aprepitant.
T453	co-administereddrug 32140 32150	Docetaxel:
T454	routeofadministration 32179 32183	oral
T455	activeingredient 32184 32194	aprepitant
T456	co-administereddrug 32253 32277	docetaxel. Vinorelbine:
T457	routeofadministration 32306 32310	oral
T458	activeingredient 32311 32321	aprepitant
T459	co-administereddrug 32379 32390	vinorelbine
T460	tradename 32459 32464	EMEND
T461	routeofadministration 32942 32946	oral
T462	activeingredient 32947 32958	aprepitant,
T463	co-administereddrug 32959 32971	ondansetron,
T464	co-administereddrug 32976 32989	dexamethasone
T465	routeofadministration 33018 33022	oral
T466	activeingredient 33240 33253	fosaprepitant
T467	activeingredient 33257 33267	aprepitant
T468	co-administereddrug 33295 33318	hormonal contraceptives
T469	activeingredient 33465 33478	fosaprepitant
T470	activeingredient 33482 33493	aprepitant.
T471	activeingredient 33622 33635	fosaprepitant
T472	activeingredient 33639 33650	aprepitant.
T473	co-administereddrug 33652 33662	Midazolam:
T474	activeingredient 33684 33694	aprepitant
T475	activeingredient 33698 33711	fosaprepitant
T476	co-administereddrug 33731 33740	midazolam
T477	activeingredient 33886 33910	Fosaprepitant/Aprepitant
T478	co-administereddrug 33931 33940	Midazolam
T479	activeingredient 33949 33974	fosaprepitant/ aprepitant
T480	co-administereddrug 33984 33993	Midazolam
T481	activeingredient 34022 34035	fosaprepitant
T482	dose 34036 34042	150 mg
T483	routeofadministration 34053 34057	oral
T484	dose 34058 34062	2 mg
T485	activeingredient 34147 34160	fosaprepitant
T486	dose 34161 34167	100 mg
T487	routeofadministration 34178 34182	oral
T488	dose 34183 34187	2 mg
T489	routeofadministration 34188 34192	oral
T490	co-administereddrug 34193 34202	midazolam
T491	routeofadministration 34234 34238	oral
T492	activeingredient 34239 34249	aprepitant
T493	dose 34250 34256	125 mg
T494	dose 34270 34275	80 mg
T495	routeofadministration 34292 34296	oral
T496	dose 34297 34301	2 mg
T497	routeofadministration 34322 34326	oral
T498	co-administereddrug 34327 34336	midazolam
T499	routeofadministration 34416 34420	oral
T500	activeingredient 34421 34431	aprepitant
T501	dose 34432 34438	125 mg
T502	dose 34452 34457	80 mg
T503	routeofadministration 34475 34486	intravenous
T504	dose 34487 34491	2 mg
T505	activeingredient 34518 34528	aprepitant
T506	routeofadministration 34554 34565	intravenous
T507	co-administereddrug 34566 34575	midazolam
T508	routeofadministration 34684 34688	oral
T509	activeingredient 34689 34699	aprepitant
T510	dose 34700 34706	125 mg
T511	routeofadministration 34707 34718	intravenous
T512	dose 34719 34723	2 mg
T513	activeingredient 34743 34753	aprepitant
T514	routeofadministration 34755 34766	intravenous
T515	co-administereddrug 34767 34776	midazolam
T516	co-administereddrug 34853 34862	midazolam
T517	co-administereddrug 34969 34978	midazolam
T518	co-administereddrug 35028 35050	alprazolam, triazolam)
T519	activeingredient 35111 35124	fosaprepitant
T520	activeingredient 35128 35139	aprepitant.
T521	co-administereddrug 35160 35183	W arfarin, Tolbutamide)
T522	co-administereddrug 35185 35194	Warfarin:
T523	dose 35204 35210	125-mg
T524	routeofadministration 35219 35223	oral
T525	activeingredient 35224 35234	aprepitant
T526	dose 35265 35270	80 mg
T527	frequency 35270 35274	/day
T528	co-administereddrug 35343 35351	warfarin
T529	routeofadministration 35393 35397	oral
T530	activeingredient 35398 35408	aprepitant
T531	co-administereddrug 35443 35451	warfarin
T532	co-administereddrug 35506 35514	warfarin
T533	routeofadministration 35681 35685	oral
T534	activeingredient 35686 35697	aprepitant.
T535	co-administereddrug 35721 35729	warfarin
T536	activeingredient 35870 35883	fosaprepitant
T537	co-administereddrug 35915 35927	Tolbutamide:
T538	routeofadministration 35928 35932	Oral
T539	activeingredient 35933 35944	aprepitant,
T540	dose 35959 35965	125 mg
T541	dose 35979 35984	80 mg
T542	frequency 35984 35988	/day
T543	co-administereddrug 36027 36038	tolbutamide
T544	co-administereddrug 36111 36122	tolbutamide
T545	dose 36123 36129	500 mg
T546	routeofadministration 36147 36153	orally
T547	routeofadministration 36206 36210	oral
T548	activeingredient 36211 36221	aprepitant
T549	activeingredient 36303 36324	Aprepitant Aprepitant
T550	activeingredient 36383 36396	fosaprepitant
T551	activeingredient 36400 36410	aprepitant
T552	activeingredient 36501 36512	aprepitant.
T553	activeingredient 36787 36800	fosaprepitant
T554	activeingredient 36804 36814	aprepitant
T555	co-administereddrug 36852 36946	ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir)
T556	activeingredient 37091 37102	aprepitant,
T557	activeingredient 37171 37181	Aprepitant
T558	activeingredient 37240 37253	fosaprepitant
T559	activeingredient 37257 37267	aprepitant
T560	co-administereddrug 37428 37441	Ketoconazole:
T561	dose 37457 37463	125-mg
T562	routeofadministration 37472 37476	oral
T563	activeingredient 37477 37487	aprepitant
T564	dose 37537 37543	400 mg
T565	frequency 37543 37547	/day
T566	co-administereddrug 37551 37564	ketoconazole,
T567	activeingredient 37603 37613	aprepitant
T568	activeingredient 37680 37690	aprepitant
T569	activeingredient 37753 37766	fosaprepitant
T570	activeingredient 37770 37780	aprepitant
T571	co-administereddrug 37845 37854	Rifampin:
T572	dose 37870 37876	375-mg
T573	routeofadministration 37885 37889	oral
T574	activeingredient 37890 37900	aprepitant
T575	dose 37950 37956	600 mg
T576	frequency 37956 37960	/day
T577	co-administereddrug 37964 37973	rifampin,
T578	activeingredient 38010 38020	aprepitant
T579	activeingredient 38138 38151	fosaprepitant
T580	activeingredient 38155 38165	aprepitant
T581	co-administereddrug 38302 38312	Diltiazem:
T582	routeofadministration 38375 38386	intravenous
T583	dose 38400 38406	100 mg
T584	activeingredient 38410 38423	fosaprepitant
T585	co-administereddrug 38429 38438	diltiazem
T586	dose 38439 38445	120 mg
T587	activeingredient 38496 38506	aprepitant
T588	co-administereddrug 38538 38547	diltiazem
T589	activeingredient 38698 38711	fosaprepitant
T590	activeingredient 38758 38759	]
T591	activeingredient 38886 38886	
T592	activeingredient 38920 38934	fosaprepitant]
T593	co-administereddrug 39095 39104	diltiazem
T594	activeingredient 39150 39160	aprepitant
T595	dose 39211 39217	230 mg
T596	co-administereddrug 39251 39260	diltiazem
T597	dose 39261 39267	120 mg
T598	frequency 39268 39281	3 times daily
T599	activeingredient 39327 39337	aprepitant
T600	co-administereddrug 39382 39391	diltiazem
T601	co-administereddrug 39544 39553	diltiazem
T602	co-administereddrug 39562 39573	Paroxetine:
T603	frequency 39594 39604	once daily
T604	activeingredient 39614 39625	aprepitant,
T605	dose 39664 39669	85 mg
T606	dose 39673 39679	170 mg
T607	co-administereddrug 39713 39723	paroxetine
T608	dose 39724 39729	20 mg
T609	frequency 39730 39741	once daily,
T610	activeingredient 39831 39841	aprepitant
T611	co-administereddrug 39846 39857	paroxetine.
T612	activeingredient 39989 40002	fosaprepitant
T613	activeingredient 40007 40018	aprepitant,
T614	activeingredient 40054 40064	aprepitant
T615	routeofadministration 40089 40093	oral
T616	activeingredient 40112 40123	aprepitant.
T617	routeofadministration 40166 40170	oral
T618	activeingredient 40180 40190	aprepitant
T619	dose 40197 40207	1000 mg/kg
T620	frequency 40208 40219	twice daily
T621	auc 40241 40263	31.3 mcg&#x2022;hr/mL,
T622	dose 40359 40367	25 mg/kg
T623	frequency 40367 40371	/day
T624	auc 40393 40415	26.9 mcg&#x2022;hr/mL,
T625	activeingredient 40547 40558	aprepitant.
T626	activeingredient 41071 41081	Aprepitant
T627	activeingredient 41315 41325	aprepitant
T628	activeingredient 41384 41394	aprepitant
T629	tradename 41624 41629	EMEND
T630	routeofadministration 41846 41850	oral
T631	activeingredient 41851 41862	aprepitant,
T632	activeingredient 42379 42392	fosaprepitant
T633	activeingredient 42396 42406	aprepitant
T634	activeingredient 42562 42575	fosaprepitant
T635	activeingredient 42579 42590	aprepitant.
T636	activeingredient 42617 42630	fosaprepitant
T637	routeofadministration 42638 42642	oral
T638	activeingredient 42643 42653	aprepitant
T639	activeingredient 42784 42795	aprepitant,
T640	activeingredient 42839 42849	Aprepitant
T641	tradename 42942 42947	EMEND
T642	activeingredient 42976 42989	fosaprepitant
T643	dose 42990 42996	150 mg
T644	routeofadministration 43022 43026	oral
T645	activeingredient 43027 43038	aprepitant,
T646	dose 43039 43045	125 mg
T647	dose 43049 43055	80 mg.
T648	tradename 43185 43190	EMEND
T649	nanoparticle 43192 43218	fosaprepitant dimeglumine)
T650	activeingredient 43270 43281	aprepitant,
T651	nanoparticle 43662 43687	Fosaprepitant dimeglumine
T652	molecularweight 43756 43764	1004.83.
T653	tradename 43797 43802	EMEND
T654	activeingredient 43845 43855	aprepitant
T655	inactiveingredient 43867 43889	polysorbate 80 (PS80),
T656	routeofadministration 43909 43922	intravenously
T657	tradename 44202 44207	EMEND
T658	dose 44222 44228	115 mg
T659	routeofadministration 44233 44244	intravenous
T660	dose 44269 44275	188 mg
T661	nanoparticle 44279 44304	fosaprepitant dimeglumine
T662	dose 44319 44325	115 mg
T663	activeingredient 44329 44342	fosaprepitant
T664	inactiveingredient 44393 44409	edetate disodium
T665	inactiveingredient 44421 44435	polysorbate 80
T666	inactiveingredient 44447 44464	lactose anhydrous
T667	inactiveingredient 44477 44493	sodium hydroxide
T668	inactiveingredient 44501 44518	hydrochloric acid
T669	tradename 44553 44558	EMEND
T670	dose 44573 44579	150 mg
T671	routeofadministration 44584 44595	intravenous
T672	dose 44620 44628	245.3 mg
T673	nanoparticle 44632 44657	fosaprepitant dimeglumine
T674	dose 44672 44678	150 mg
T675	activeingredient 44682 44695	fosaprepitant
T676	inactiveingredient 44746 44762	edetate disodium
T677	inactiveingredient 44774 44788	polysorbate 80
T678	inactiveingredient 44798 44815	lactose anhydrous
T679	inactiveingredient 44826 44842	sodium hydroxide
T680	inactiveingredient 44850 44867	hydrochloric acid
T681	nanoparticle 44889 44914	Fosaprepitant dimeglumine
T682	activeingredient 44948 44962	fosaprepitant.
T683	activeingredient 44990 45004	Fosaprepitant,
T684	activeingredient 45018 45029	aprepitant,
T685	routeofadministration 45048 45061	intravenously
T686	activeingredient 45086 45097	aprepitant,
T687	activeingredient 45177 45190	fosaprepitant
T688	dose 45344 45350	188 mg
T689	nanoparticle 45354 45379	fosaprepitant dimeglumine
T690	dose 45395 45401	115-mg
T691	activeingredient 45402 45415	fosaprepitant
T692	activeingredient 45430 45441	aprepitant,
T693	dose 45526 45534	245.3 mg
T694	nanoparticle 45538 45563	fosaprepitant dimeglumine
T695	dose 45579 45585	150-mg
T696	activeingredient 45586 45599	fosaprepitant
T697	activeingredient 45614 45625	aprepitant,
T698	activeingredient 45719 45732	Fosaprepitant
T699	activeingredient 45749 45759	aprepitant
T700	activeingredient 45821 45843	aprepitant. Aprepitant
T701	activeingredient 45936 45946	Aprepitant
T702	activeingredient 46123 46133	Aprepitant
T703	activeingredient 46335 46345	aprepitant
T704	activeingredient 46466 46476	aprepitant
T705	routeofadministration 46819 46823	oral
T706	activeingredient 46824 46834	aprepitant
T707	dose 46844 46849	10 mg
T708	dose 46857 46862	30 mg
T709	dose 46870 46876	100 mg
T710	dose 46886 46892	300 mg
T711	frequency 46899 46909	once daily
T712	duration 46914 46921	14 days
T713	activeingredient 46967 46977	aprepitant
T714	activeingredient 47138 47148	aprepitant
T715	routeofadministration 47267 47271	oral
T716	activeingredient 47272 47282	aprepitant
T717	activeingredient 47328 47338	aprepitant
T718	activeingredient 47681 47691	aprepitant
T719	dose 47826 47832	200-mg
T720	activeingredient 47842 47855	fosaprepitant
T721	activeingredient 47914 47924	Aprepitant
T722	activeingredient 47931 47944	Fosaprepitant
T723	routeofadministration 47980 47991	intravenous
T724	dose 47992 47998	115-mg
T725	activeingredient 48007 48020	fosaprepitant
T726	activeingredient 48106 48116	aprepitant
T727	auc 48121 48150	31.7 ( 14.3) mcg&#x2022;hr/mL
T728	activeingredient 48172 48182	aprepitant
T729	cmax 48208 48228	3.27 ( 1.16) mcg/mL.
T730	activeingredient 48238 48248	aprepitant
T731	dose 48315 48321	125-mg
T732	routeofadministration 48322 48326	oral
T733	activeingredient 48327 48337	aprepitant
T734	dose 48351 48357	115-mg
T735	routeofadministration 48358 48369	intravenous
T736	activeingredient 48370 48383	fosaprepitant
T737	activeingredient 48608 48618	Aprepitant
T738	dose 48629 48635	125-mg
T739	routeofadministration 48636 48640	Oral
T740	activeingredient 48641 48651	Aprepitant
T741	dose 48656 48662	115-mg
T742	routeofadministration 48663 48674	Intravenous
T743	activeingredient 48676 48689	Fosaprepitant
T744	activeingredient 48728 48740	A prep itant
T745	dose 48795 48801	125-mg
T746	routeofadministration 48802 48806	Oral
T747	activeingredient 48807 48817	Aprepitant
T748	dose 48818 48824	115-mg
T749	routeofadministration 48825 48827	IV
T750	activeingredient 48828 48841	Fosaprepitant
T751	routeofadministration 48895 48906	intravenous
T752	dose 48907 48913	150-mg
T753	activeingredient 48922 48935	fosaprepitant
T754	activeingredient 49022 49032	aprepitant
T755	auc 49037 49068	37.38 ( 14.75) mcg&#x2022;hr/mL
T756	activeingredient 49090 49100	aprepitant
T757	cmax 49126 49146	4.15 ( 1.15) mcg/mL.
T758	activeingredient 49161 49174	Fosaprepitant
T759	activeingredient 49199 49221	aprepitant. Aprepitant
T760	volumeofdistribution 49350 49354	70 L
T761	activeingredient 49367 49377	Aprepitant
T762	activeingredient 49513 49526	Fosaprepitant
T763	activeingredient 49552 49562	aprepitant
T764	activeingredient 49676 49689	fosaprepitant
T765	activeingredient 49740 49750	aprepitant
T766	activeingredient 49878 49891	fosaprepitant
T767	activeingredient 49895 49905	aprepitant
T768	activeingredient 49986 49999	fosaprepitant
T769	routeofadministration 50013 50026	intravenously
T770	activeingredient 50052 50062	aprepitant
T771	activeingredient 50113 50123	Aprepitant
T772	activeingredient 50216 50226	aprepitant
T773	activeingredient 50469 50479	aprepitant
T774	routeofadministration 50575 50579	oral
T775	dose 50580 50586	300-mg
T776	activeingredient 50601 50612	aprepitant,
T777	activeingredient 50698 50709	aprepitant,
T778	routeofadministration 50826 50837	intravenous
T779	dose 50838 50844	100-mg
T780	activeingredient 50859 50872	fosaprepitant
T781	activeingredient 50961 50971	Aprepitant
T782	activeingredient 51011 51021	aprepitant
T783	plasmahalflife 51106 51120	9 to 13 hours.
T784	routeofadministration 51431 51435	oral
T785	activeingredient 51471 51482	aprepitant,
T786	activeingredient 51581 51591	aprepitant
T787	dose 51851 51857	125-mg
T788	activeingredient 51866 51876	aprepitant
T789	dose 51890 51895	80 mg
T790	frequency 51896 51906	once daily
T791	activeingredient 51946 51956	aprepitant
T792	routeofadministration 52290 52294	oral
T793	activeingredient 52330 52341	aprepitant,
T794	activeingredient 52793 52803	aprepitant
T795	activeingredient 53012 53025	Fosaprepitant
T796	activeingredient 53147 53160	fosaprepitant
T797	activeingredient 53164 53175	aprepitant.
T798	dose 53213 53219	125-mg
T799	routeofadministration 53228 53232	oral
T800	activeingredient 53233 53243	aprepitant
T801	dose 53257 53262	80 mg
T802	activeingredient 53376 53386	aprepitant
T803	activeingredient 53581 53591	aprepitant
T804	dose 54057 54063	240-mg
T805	routeofadministration 54072 54076	oral
T806	activeingredient 54077 54087	aprepitant
T807	activeingredient 54390 54400	aprepitant
T808	activeingredient 54650 54660	aprepitant
T809	activeingredient 54751 54761	aprepitant
T810	activeingredient 55043 55054	aprepitant;
T811	routeofadministration 55680 55684	oral
T812	dose 55704 55722	0.05 to 1000 mg/kg
T813	frequency 55723 55735	twice daily.
T814	activeingredient 55785 55795	aprepitant
T815	auc 55867 55889	19.6 mcg&#x2022;hr/mL)
T816	dose 55917 55923	125 mg
T817	frequency 55923 55928	/day.
T818	activeingredient 55944 55954	aprepitant
T819	dose 55967 55982	5 to 1000 mg/kg
T820	frequency 55983 55994	twice daily
T821	dose 56152 56167	5 to 1000 mg/kg
T822	frequency 56168 56179	twice daily
T823	dose 56250 56267	125 to 1000 mg/kg
T824	frequency 56268 56280	twice daily.
T825	routeofadministration 56349 56353	oral
T826	dose 56373 56390	2.5 to 2000 mg/kg
T827	frequency 56390 56395	/day.
T828	activeingredient 56527 56537	aprepitant
T829	dose 56569 56586	125 and 500 mg/kg
T830	frequency 56586 56590	/day
T831	activeingredient 56659 56685	fosaprepitant. Aprepitant
T832	activeingredient 56690 56703	fosaprepitant
T833	activeingredient 56935 56949	Fosaprepitant,
T834	routeofadministration 56968 56982	intravenously,
T835	activeingredient 57007 57018	aprepitant.
T836	activeingredient 57059 57072	fosaprepitant
T837	activeingredient 57077 57088	aprepitant,
T838	activeingredient 57123 57133	aprepitant
T839	routeofadministration 57158 57162	oral
T840	activeingredient 57181 57192	aprepitant.
T841	routeofadministration 57193 57197	Oral
T842	activeingredient 57198 57208	aprepitant
T843	dose 57341 57351	1000 mg/kg
T844	frequency 57352 57363	twice daily
T845	activeingredient 57541 57555	Fosaprepitant,
T846	activeingredient 57569 57580	aprepitant,
T847	routeofadministration 57599 57612	intravenously
T848	activeingredient 57637 57648	aprepitant.
T849	routeofadministration 57650 57654	Oral
T850	activeingredient 57673 57683	aprepitant
T851	co-administereddrug 57704 57715	ondansetron
T852	co-administereddrug 57720 57733	dexamethasone
T853	activeingredient 57735 57745	aprepitant
T854	indication 57773 57818	prevent acute and delayed nausea and vomiting
T855	indication 57835 57865	highly emetogenic chemotherapy
T856	indication 57979 58015	Highly Emetogenic Chemotherapy (HEC)
T857	tradename 58016 58021	EMEND
T858	dose 58036 58042	115 mg
T859	tradename 58068 58074	EMEND)
T860	activeingredient 58076 58089	Fosaprepitant
T861	dose 58090 58096	115 mg
T862	routeofadministration 58097 58108	intravenous
T863	dose 58156 58162	125 mg
T864	routeofadministration 58163 58167	oral
T865	activeingredient 58168 58178	aprepitant
T866	routeofadministration 58268 58272	oral
T867	activeingredient 58273 58284	aprepitant.
T868	activeingredient 58373 58383	aprepitant
T869	co-administereddrug 58501 58510	cisplatin
T870	dose 58511 58523	&gt;50 mg/m2
T871	co-administereddrug 58530 58539	cisplatin
T872	dose 58547 58558	80.2 mg/m2)
T873	activeingredient 58615 58625	aprepitant
T874	activeingredient 58741 58759	aprepitant-treated
T875	activeingredient 58989 58999	aprepitant
T876	indication 59311 59341	Highly Emetogenic Chemotherapy
T877	activeingredient 59380 59390	Aprepitant
T878	activeingredient 59399 59409	Aprepitant
T879	dose 59410 59416	125 mg
T880	routeofadministration 59418 59424	orally
T881	dose 59425 59430	80 mg
T882	routeofadministration 59431 59437	orally
T883	dose 59438 59443	80 mg
T884	routeofadministration 59444 59450	orally
T885	co-administereddrug 59457 59470	Dexamethasone
T886	dose 59471 59476	12 mg
T887	routeofadministration 59477 59483	orally
T888	dose 59484 59488	8 mg
T889	routeofadministration 59489 59495	orally
T890	dose 59496 59500	8 mg
T891	routeofadministration 59501 59507	orally
T892	dose 59508 59512	8 mg
T893	routeofadministration 59513 59519	orally
T894	co-administereddrug 59603 59616	Dexamethasone
T895	dose 59617 59622	20 mg
T896	routeofadministration 59623 59629	orally
T897	dose 59630 59634	8 mg
T898	routeofadministration 59635 59641	orally
T899	dose 59655 59659	8 mg
T900	routeofadministration 59660 59666	orally
T901	frequency 59667 59678	twice daily
T902	dose 59680 59684	8 mg
T903	routeofadministration 59685 59691	orally
T904	frequency 59692 59703	twice daily
T905	co-administereddrug 59843 59854	Ondansetron
T906	dose 59855 59860	32 mg
T907	routeofadministration 59861 59865	I.V.
T908	activeingredient 59901 59912	aprepitant.
T909	co-administereddrug 60025 60036	ondansetron
T910	activeingredient 60126 60136	aprepitant
T911	activeingredient 60291 60301	aprepitant
T912	routeofadministration 60502 60506	oral
T913	activeingredient 60507 60517	aprepitant
T914	activeingredient 62002 62012	Aprepitant
T915	activeingredient 63256 63266	Aprepitant
T916	activeingredient 64664 64674	aprepitant
T917	activeingredient 64886 64896	aprepitant
T918	activeingredient 65105 65115	aprepitant
T919	activeingredient 65178 65188	aprepitant
T920	indication 65333 65363	Highly Emetogenic Chemotherapy
T921	activeingredient 65431 65441	Aprepitant
T922	activeingredient 65482 65492	Aprepitant
T923	activeingredient 66205 66215	aprepitant
T924	activeingredient 66742 66752	Aprepitant
T925	activeingredient 66802 66812	Aprepitant
T926	activeingredient 66839 66849	Aprepitant
T927	indication 67248 67278	Highly Emetogenic Chemotherapy
T928	tradename 67350 67355	EMEND
T929	dose 67370 67376	150 mg
T930	tradename 67401 67413	EMEND) EMEND
T931	dose 67428 67434	150 mg
T932	tradename 67548 67553	EMEND
T933	indication 67562 67595	prevention of nausea and vomiting
T934	indication 67607 67611	HEC.
T935	tradename 67679 67684	EMEND
T936	dose 67699 67705	150 mg
T937	routeofadministration 67741 67745	oral
T938	activeingredient 67746 67756	aprepitant
T939	indication 67819 67849	highly emetogenic chemotherapy
T940	dose 67883 67900	&#x2265;70 mg/m2)
T941	tradename 68007 68012	EMEND
T942	activeingredient 68035 68046	aprepitant,
T943	indication 68339 68342	HEC
T944	indication 68398 68428	Highly Emetogenic Chemotherapy
T945	activeingredient 68466 68479	Fosaprepitant
T946	activeingredient 68489 68502	Fosaprepitant
T947	dose 68503 68509	150 mg
T948	routeofadministration 68510 68523	intravenously
T949	co-administereddrug 68541 68554	Dexamethasone
T950	dose 68555 68560	12 mg
T951	routeofadministration 68561 68567	orally
T952	dose 68568 68572	8 mg
T953	routeofadministration 68573 68579	orally
T954	dose 68581 68585	8 mg
T955	routeofadministration 68586 68592	orally
T956	frequency 68593 68604	twice daily
T957	dose 68606 68610	8 mg
T958	routeofadministration 68611 68617	orally
T959	frequency 68618 68629	twice daily
T960	activeingredient 68689 68699	Aprepitant
T961	activeingredient 68709 68719	Aprepitant
T962	dose 68720 68726	125 mg
T963	routeofadministration 68727 68733	orally
T964	dose 68734 68739	80 mg
T965	routeofadministration 68740 68746	orally
T966	dose 68748 68753	80 mg
T967	routeofadministration 68754 68760	orally
T968	co-administereddrug 68767 68780	Dexamethasone
T969	dose 68781 68786	12 mg
T970	routeofadministration 68787 68793	orally
T971	dose 68794 68798	8 mg
T972	routeofadministration 68799 68805	orally
T973	dose 68807 68811	8 mg
T974	routeofadministration 68812 68818	orally
T975	dose 68819 68823	8 mg
T976	routeofadministration 68824 68830	orally
T977	co-administereddrug 69029 69040	Ondansetron
T978	dose 69041 69046	32 mg
T979	routeofadministration 69047 69051	I.V.
T980	tradename 69086 69091	EMEND
T981	co-administereddrug 69221 69232	ondansetron
T982	activeingredient 69289 69302	fosaprepitant
T983	dose 69303 69309	150 mg
T984	routeofadministration 69448 69452	oral
T985	activeingredient 69453 69463	aprepitant
T986	indication 70046 70076	Highly Emetogenic Chemotherapy
T987	activeingredient 70139 70152	Fosaprepitant
T988	activeingredient 70178 70188	Aprepitant
T989	indication 70863 70903	Moderately Emetogenic Chemotherapy (MEC)
T990	activeingredient 71011 71021	aprepitant
T991	indication 71114 71148	moderately emetogenic chemotherapy
T992	co-administereddrug 71171 71187	cyclophosphamide
T993	dose 71188 71203	750-1500 mg/m2;
T994	co-administereddrug 71207 71223	cyclophosphamide
T995	dose 71224 71238	500-1500 mg/m2
T996	co-administereddrug 71243 71254	doxorubicin
T997	dose 71256 71273	&#x2264;60 mg/m2)
T998	co-administereddrug 71277 71287	epirubicin
T999	dose 71289 71307	&#x2264;100 mg/m2)
T1000	co-administereddrug 71359 71375	cyclophosphamide
T1001	co-administereddrug 71378 71389	doxorubicin
T1002	co-administereddrug 71403 71419	cyclophosphamide
T1003	co-administereddrug 71422 71432	epirubicin
T1004	co-administereddrug 71435 71447	fluorouracil
T1005	activeingredient 71513 71523	aprepitant
T1006	activeingredient 71647 71665	aprepitant-treated
T1007	activeingredient 71886 71896	aprepitant
T1008	indication 72255 72289	Moderately Emetogenic Chemotherapy
T1009	activeingredient 72321 72331	Aprepitant
T1010	activeingredient 72341 72351	Aprepitant
T1011	dose 72352 72358	125 mg
T1012	routeofadministration 72359 72366	orally*
T1013	dose 72368 72373	80 mg
T1014	routeofadministration 72374 72380	orally
T1015	dose 72381 72386	80 mg
T1016	routeofadministration 72387 72393	orally
T1017	co-administereddrug 72394 72407	Dexamethasone
T1018	dose 72408 72413	12 mg
T1019	routeofadministration 72414 72428	orally&#x2022;
T1020	co-administereddrug 72439 72450	Ondansetron
T1021	dose 72451 72455	8 mg
T1022	routeofadministration 72456 72462	orally
T1023	co-administereddrug 72507 72520	Dexamethasone
T1024	dose 72521 72526	20 mg
T1025	routeofadministration 72527 72533	orally
T1026	co-administereddrug 72544 72555	Ondansetron
T1027	dose 72556 72560	8 mg
T1028	routeofadministration 72561 72567	orally
T1029	dose 72578 72582	8 mg
T1030	routeofadministration 72583 72589	orally
T1031	frequency 72590 72602	twice daily
T1032	dose 72603 72607	8 mg
T1033	routeofadministration 72608 72614	orally
T1034	frequency 72615 72627	twice daily
T1035	co-administereddrug 72745 72758	Dexamethasone
T1036	co-administereddrug 72828 72839	Ondansetron
T1037	co-administereddrug 72939 72950	ondansetron
T1038	routeofadministration 72985 72989	oral
T1039	activeingredient 72990 73000	aprepitant
T1040	activeingredient 74025 74035	Aprepitant
T1041	activeingredient 74666 74676	aprepitant
T1042	activeingredient 75293 75303	aprepitant
T1043	activeingredient 75838 75848	aprepitant
T1044	activeingredient 76284 76294	aprepitant
T1045	activeingredient 76476 76486	aprepitant
T1046	routeofadministration 76641 76643	IV
T1047	routeofadministration 76770 76772	IV
T1048	dose 76774 76789	&lt;1500 mg/m2)
T1049	routeofadministration 76805 76807	IV
T1050	dose 76809 76820	&gt;1 g/m2)
T1051	activeingredient 76878 76888	aprepitant
T1052	activeingredient 77107 77124	aprepitanttreated
T1053	activeingredient 77339 77349	aprepitant
T1054	tradename 77596 77601	EMEND
T1055	activeingredient 78032 78042	Aprepitant
T1056	activeingredient 78426 78436	aprepitant
T1057	activeingredient 78619 78629	aprepitant
T1058	activeingredient 78886 78896	aprepitant
T1059	activeingredient 79177 79187	aprepitant
T1060	activeingredient 79442 79452	aprepitant
T1061	activeingredient 79799 79809	aprepitant
T1062	dose 80092 80098	115-mg
T1063	dose 80235 80241	150-mg
T1064	routeofadministration 80435 80446	intravenous
T1065	tradename 80692 80697	EMEND
T1066	tradename 80828 80833	EMEND
T1067	adversereaction 80857 80876	Allergic reactions,
T1068	adversereaction 80929 80976	hives, rash, itching, redness of the face/skin
T1069	adversereaction 80991 81029	difficulty in breathing or swallowing,
T1070	tradename 81106 81111	EMEND
T1071	adversereaction 81167 81185	allergic reaction.
T1072	adversereaction 81199 81220	severe skin reactions
T1073	adversereaction 81264 81286	infusion site reaction
T1074	adversereaction 81295 81317	erythema, edema, pain,
T1075	adversereaction 81321 81337	thrombophlebitis
T1076	tradename 81435 81440	EMEND
T1077	co-administereddrug 81676 81684	warfarin
T1078	activeingredient 81838 81851	fosaprepitant
T1079	tradename 81901 81906	EMEND
T1080	co-administereddrug 81948 81972	hormonal contraceptives.
T1081	activeingredient 82120 82133	fosaprepitant
T1082	activeingredient 82137 82148	aprepitant.
T1083	company 82169 82199	Merck Sharp &amp; Dohme Corp.,
T1084	company 82216 82238	MERCK &amp; CO., INC.,
T1085	company 82294 82320	DSM Pharmaceuticals, Inc.,
T1086	u.s.patent 82404 82424	5,512,570; 5,691,336
T1087	company 82448 82478	Merck Sharp &amp; Dohme Corp.,
T1088	company 82495 82516	Merck &amp; Co., Inc.
